Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
BALPHARMA

Bal Pharma Share Price

 

 

Bal Pharma live price: ₹79.6. It opened at ₹80 vs previous close ₹80; intraday high/low: ₹82/₹79. The 50 & 200 DMA stand at ₹75.07/₹79.88.

Bal Pharma Performance

  • Today's Low
  • ₹79
  • Today's High
  • ₹82
  • 52 Week Low
  • ₹60
  • 52 Week High
  • ₹111
  • Open Price₹80
  • Previous Close₹80
  • Volume5,157
  • 50 DMA₹75.07
  • 100 DMA₹75.18
  • 200 DMA₹79.88

Bal Pharma Chart

Investment Returns

  • Over 1 Month + 5.88%
  • Over 3 Month + 5.84%
  • Over 6 Month -0.38%
  • Over 1 Year -21.07%

Smart Investing Starts Here Start SIP with Bal Pharma for Steady Growth!

Invest Now

Bal Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 15.6
  • PEG Ratio
  • 1.3
  • Market Cap Cr
  • 127
  • P/B Ratio
  • 1.6
  • Average True Range
  • 3.72
  • EPS
  • 5.1
  • Dividend Yield
  • 1.5
  • MACD Signal
  • 1.87
  • RSI
  • 58.23
  • MFI
  • 74.14

Bal Pharma Financials

Bal Pharma Technicals

EMA & SMA

Current Price
₹79.60
-0.74 (-0.92%)
pointer
  • Bearish Moving Average 3
  • Bullish Moving Average 13
  • 20 Day
  • ₹77.68
  • 50 Day
  • ₹75.07
  • 100 Day
  • ₹75.18
  • 200 Day
  • ₹79.88

Resistance and Support

80.93 Pivot Speed
  • R3 84.29
  • R2 83.37
  • R1 81.85
  • S1 79.41
  • S2 78.49
  • S3 76.97

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Bal Pharma has an operating revenue of Rs. 309.46 Cr. on a trailing 12-month basis. An annual revenue de-growth of -11% needs improvement, Pre-tax margin of 2% needs improvement, ROE of 9% is fair but needs improvement. The company has a reasonable debt to equity of 41%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 200DMA and around 10% above its 50DMA. It needs to stay above the 200DMA levels to make any further meaningful move. It has recently broken out of a base in its weekly chart and is trading around -1% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 60 which is a FAIR score but needs to improve its earnings, a RS Rating of 58 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 62 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Bal Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-11 Quarterly Results
2025-11-12 Quarterly Results
2025-08-11 Quarterly Results, ESOP & A.G.M.
2025-05-29 Audited Results & Dividend
2025-02-13 Quarterly Results & Fund Raising
Date Purpose Remarks
2025-09-18 FINAL Rs.1.20 per share(12%)Dividend
View Bal Pharma Dividend History Arrow

Bal Pharma Shareholding Pattern

50.86%
0.14%
32.84%
16.16%

Bal Pharma FAQs

Bal Pharma share price is ₹79 As on 14 May, 2026 | 13:46

The Market Cap of Bal Pharma is ₹126.7 Cr As on 14 May, 2026 | 13:46

The P/E ratio of Bal Pharma is 15.6 As on 14 May, 2026 | 13:46

The PB ratio of Bal Pharma is 1.6 As on 14 May, 2026 | 13:46

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23